It is known that IL-10 protects from carcinogenic and improves tumor immune surveillance, besides inhibiting tumor migration and progression, particularly in the early stages of breast cancer (Mumm et al., 2011; Holen et al., 2016). Here, IL10 is linked to breast cancer.